---
$id: https://graph.org.ai/products/commodity/51202404
$type: Product
source: UNSPSC
code: "51202404"
title: "Canakinumab"
class: "51202400"
classTitle: "Immunosupressant antibodies"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Canakinumab

**UNSPSC Code**: 51202404
**Class**: [Immunosupressant antibodies](Immunosupressant antibodies.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoclonal antibody with the molecular formula C6452H9958N1722O2010S42, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 37CQ2C7X93, more generally known as canakinumab. European Medicines Agency schedules canakinumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30137. The term CANAKINUMAB is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 22, No. 1, 2008, list 59. As of Q4 2014, CANAKINUMAB remains US FDA's Preferred Term for this commodity.

